Clinical Trial Update: SABR PRIMER - Evaluating Stereotactic Ablative Radiotherapy for Primary and Regional Breast Tumors [NA]

View source ↗

Summary

This clinical trial update describes SABR PRIMER, evaluating stereotactic ablative radiotherapy for primary and regional breast tumors; the study is not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Breast Cancer, Metastases | NA | Status: NOT_YET_RECRUITING